While GLP-1 RAs are not typically prescribed solely as injectable treatments for depression, their impact on overall well-being, including mood, is a significant area of ongoing research
Medicines and Healthcare products Regulatory Agency (MHRA) has told users of GLP-1s and healthcare professionals to be 'aware and alert' of symptoms, which include severe, persistent stomach pain that may radiate to the back and may be accompanied by nausea and vomiting
Visceral fat, the kind stored around organs in the abdominal cavity rather than under the skin, is directly linked to metabolic syndrome, insulin resistance, and cardiovascular risk
Most oncologists prefer you to have finished active treatment (surgery, chemotherapy, radiotherapy) and have documented complete remission